Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin (SitaDFU)
The purpose of the study is to test the effect of Sitagliptin on the healing of stable, nonhealing diabetic foot ulcers. This is a randomized placebo-controlled Trial.
Study Type: Interventional
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin
Estimated Enrollment: 40
Study Start Date: March 2016
Estimated Study Completion Date: March 2018
Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)
Arms:
- Active Comparator: Sitagliptin
- Placebo Comparator: Placebo
Category | Value |
---|---|
Study start date | 2016-03-01 |